Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

RegulatoryPEPTIgray-marketprescribingbpc-157

PEPTI routes every order through physician review as bootleg peptide reports climb

With poison center calls tied to unapproved retatrutide at 862, PEPTI's catalog moves only on patient-specific prescriptions after an online intake.

DO
By Daniel Okafor · Regulatory Correspondent
Oct 19 07:37 ETSource: PEPTI

The wire

  1. 01PEPTI sells roughly 40 peptides, including BPC-157 at $249 and PT-141 at $259, each dispensed only after a licensed physician reviews an online intake.
  2. 02This week's wire logs 862 poison center calls on bootleg retatrutide, two reported deaths, and a warning letter to an online seller of unapproved semaglutide.
  3. 03Unclear how federal enforcement shifts under the interim access policy now with the White House, or whether prescription-channel volume moves with it.

From the source

Gray-market peptide all-in cost

Read at hellopepti.com
PeptiPrescribed peptides from $99/moSee all →